Seeing Is Believing
Currently out of the existing stock ratings of Suraj Kalia, 114 are a BUY (72.61%), 19 are a HOLD (12.1%), 24 are a SELL (15.29%).
Analyst Suraj Kalia, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 57.41% that have a potential upside of 33.44% achieved within 198 days.
Suraj Kalia’s has documented 348 price targets and ratings displayed on 36 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PODD, Insulet at 08-Sep-2025.
Analyst best performing recommendations are on ISR (ISORAY).
The best stock recommendation documented was for ATRC (ATRICURE) at 4/28/2021. The price target of $75 was fulfilled within 1 day with a profit of $5.15 (7.37%) receiving and performance score of 73.73.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$388
$6.98 (1.83%)
$355
2 years 11 months 8 days ago
(01-Nov-2022)
2/5 (40%)
$14.49 (3.88%)
88
Hold
$380
$-1.02 (-0.27%)
$235
2 years 11 months 8 days ago
(01-Nov-2022)
1/2 (50%)
$6.49 (1.74%)
36
Hold
$380
$-1.02 (-0.27%)
$350
2 years 11 months 9 days ago
(31-Oct-2022)
24/41 (58.54%)
$2.18 (0.58%)
138
Buy
$300
$-81.02 (-21.26%)
$425
2 years 11 months 27 days ago
(12-Oct-2022)
1/2 (50%)
$41.92 (16.24%)
19
Sell
$235
$-146.02 (-38.32%)
$275
3 years 2 months 25 days ago
(14-Jul-2022)
6/8 (75%)
$-33.23 (-12.39%)
143
Which stock is Suraj Kalia is most bullish on?
Which stock is Suraj Kalia is most reserved on?
What Year was the first public recommendation made by Suraj Kalia?